HCPLive

Atherosclerosis

Latest Headlines

ACC 2015
ACC 2015
More than 13,000 physicians and cardiovascular team members attended the ACC 2015 meeting in San Diego on March 14-16, 2015. In this issue of Cardiology Review, we focus on 6 important studies presented at ACC 2015: LEGACY, OSLER, PEGASUS, EMBRACE-STEMI, MATRIX, and CoreValve.
A Comparison of Fractional Flow Reserve by Coronary Angiography Vs. Atherosclerotic Plaque Characteristics by Coronary CTA
In the era of progressive technology, the diagnostic modalities for stable coronary artery disease are various. The original cardiac stress test has been used in the past for many purposes, including diagnosis of obstructive coronary artery disease in a patient with chest pain as well as risk stratification for ischemia. More recently, coronary computed tomographic angiography (CCTA) has emerged as a great tool to diagnose anatomically obstructive coronary lesions. However, for the past few years, obtaining functional and physiologic data such as comparative fractional flow reserve (FFR) has become the gold standard for evidence of ischemia on CCTA similar to invasive angiography.
LDL: How Low Should We Go?
In this segment of the Peer Exchange, the panelists discuss clinical factors that should be taken into consideration when placing a patient on statin therapy to lower their LDL levels. They also talk about the strengths and weaknesses of the clinical data being used to inform treatment decisions.
Can Ezetimibe Improve Statin Outcomes?
The panelists discuss clinical outcomes in patients with acute coronary syndrome treated with statins and other medications and review the implications of the results from the IMPROVE-IT trial.
When Is it Appropriate to Use Vitamin D Supplementation?
In this segment of the Peer Exchange, the panelists discuss whether the available evidence supports the use of vitamin D supplementation in preventing cardiovascular disease.
Tocilizumab Reduces LDL-C in Patients with Rheumatoid Arthritis
LDL-C was reduced in RA patients who took tocilizumab compared to placebo in a study published in Annals of the Rheumatic Diseases.

Most Popular

$vacMongoViewPlus$ $vAR$